Michael S Phillips
Overview
Explore the profile of Michael S Phillips including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
5052
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Lachance K, Barhdadi A, Mongrain I, Normand V, Zakrzewski M, Leblanc M, et al.
Pharmacogenet Genomics
. 2012 Feb;
22(5):336-43.
PMID: 22322241
Objectives: Single nucleotide polymorphisms (SNPs) in the transforming growth factor-β1 gene (TGFB1) have been inconsistently associated with calcineurin inhibitor (CNI)-induced renal dysfunction following cardiac transplantation. The impact of genetic variants...
32.
Doan L, Piskoun B, Rosenberg A, Blanck T, Phillips M, Xu F
Reg Anesth Pain Med
. 2011 Dec;
37(2):131-8.
PMID: 22189621
Background And Objective: Chlorhexidine is recommended by several anesthesiology societies for antisepsis before regional anesthesia, but there is concern it may be neurotoxic. We evaluated the cytotoxicity of chlorhexidine and...
33.
Visscher H, Ross C, Rassekh S, Barhdadi A, Dube M, Al-Saloos H, et al.
J Clin Oncol
. 2011 Sep;
30(13):1422-8.
PMID: 21900104
Purpose: Anthracycline-induced cardiotoxicity (ACT) is a serious adverse drug reaction limiting anthracycline use and causing substantial morbidity and mortality. Our aim was to identify genetic variants associated with ACT in...
34.
35.
Bouffard M, Phillips M, Brown A, Marsh S, Tardif J, Van Rooij T
Database (Oxford)
. 2010 Dec;
2010:baq029.
PMID: 21159730
Data generation, driven by rapid advances in genomic technologies, is fast outpacing our analysis capabilities. Faced with this flood of data, more hardware and software resources are added to accommodate...
36.
Hamdan F, Daoud H, Rochefort D, Piton A, Gauthier J, Langlois M, et al.
Am J Hum Genet
. 2010 Oct;
87(5):671-8.
PMID: 20950788
Heterozygous mutations in FOXP2, which encodes a forkhead transcription factor, have been shown to cause developmental verbal dyspraxia and language impairment. FOXP2 and its closest homolog, FOXP1, are coexpressed in...
37.
Brown A, Lo K, Guelpa P, Beaudoin M, Rioux J, Tardif J, et al.
BMC Res Notes
. 2010 Jul;
3:185.
PMID: 20609249
Background: Polymerase chain reaction (PCR) remains a simple, flexible, and inexpensive method for enriching genomic regions of interest for next-generation sequencing. In order to utilize PCR in this context, a...
38.
Slover J, Haas J, Quirno M, Phillips M, Bosco 3rd J
J Arthroplasty
. 2010 May;
26(3):360-5.
PMID: 20452175
We conducted a Markov decision analysis to assess the cost savings associated with a preoperative Staphylococcus aureus screening and decolonization program on 365 hip and knee arthroplasties and 287 spine...
39.
Ross C, Katzov-Eckert H, Dube M, Brooks B, Rassekh S, Barhdadi A, et al.
Nat Genet
. 2009 Nov;
41(12):1345-9.
PMID: 19898482
Cisplatin is a widely used and effective chemotherapeutic agent, although its use is restricted by the high incidence of irreversible ototoxicity associated with it. In children, cisplatin ototoxicity is a...
40.
Ciszkowski C, Madadi P, Phillips M, Lauwers A, Koren G
N Engl J Med
. 2009 Aug;
361(8):827-8.
PMID: 19692698
No abstract available.